Carlton D Dampier
Overview
Explore the profile of Carlton D Dampier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walters M, Eapen M, Liu Y, El Rassi F, Waller E, Levine J, et al.
Blood Adv
. 2024 Oct;
9(5):955-965.
PMID: 39471440
Disease-modifying therapies are standard of care (SOC) for sickle cell disease (SCD), but hematopoietic cell transplantation (HCT) has curative potential. We compared outcomes prospectively through 2 years after biologic assignment...
2.
Dampier C, Telen M, Wun T, Brown R, Desai P, El Rassi F, et al.
Blood
. 2022 Aug;
141(2):168-179.
PMID: 35981565
The efficacy and safety of rivipansel, a predominantly E-selectin antagonist, were studied in a phase 3, randomized, controlled trial for vaso-occlusive crisis (VOC) requiring hospitalization (RESET). A total of 345...
3.
Morris C, Brown L, Reynolds M, Dampier C, Lane P, Watt A, et al.
Blood
. 2020 May;
136(12):1402-1406.
PMID: 32384147
Altered mitochondrial function occurs in sickle cell disease (SCD), due in part to low nitric oxide (NO) bioavailability. Arginine, the substrate for NO production, becomes acutely deficient in SCD patients...
4.
Palermo T, Zempsky W, Dampier C, Lalloo C, Hundert A, Murphy L, et al.
Contemp Clin Trials
. 2018 Oct;
74:88-96.
PMID: 30316999
Many adolescents with sickle cell disease (SCD) experience recurrent and chronic pain, which has a negative impact on their health-related quality of life (HRQL). Cognitive-behavioral therapy (CBT) interventions can lead...
5.
Daak A, Dampier C, Fuh B, Kanter J, Alvarez O, Black L, et al.
Blood Adv
. 2018 Aug;
2(15):1969-1979.
PMID: 30097463
Blood cell membranes in sickle cell disease (SCD) have low docosahexaenoic acid (DHA). DHA treatment reduces sickle cell crisis (SCC) rate and ameliorates the inflammation, oxidative stress, and hypercoagulable state...
6.
Walco G, Kopecky E, Weisman S, Stinson J, Stevens B, Desjardins P, et al.
Pain
. 2017 Nov;
159(2):193-205.
PMID: 29140927
Clinical trials to test the safety and efficacy of analgesics across all pediatric age cohorts are needed to avoid inappropriate extrapolation of adult data to children. However, the selection of...
7.
DeWalt D, Gross H, Gipson D, Selewski D, Morgan DeWitt E, Dampier C, et al.
Qual Life Res
. 2015 Feb;
24(9):2195-208.
PMID: 25715946
Purpose: To conduct a comparative analysis of eight pediatric self-report scales for ages 8-17 years from the National Institutes of Health (NIH) Patient Reported Outcomes Measurement Information System (PROMIS(®)) in...
8.
Dampier C, Smith W, Wager C, Kim H, Bell M, Miller S, et al.
Clin Trials
. 2013 Mar;
10(2):319-31.
PMID: 23539110
Background: The hallmark of sickle cell disease (SCD) is pain from a vaso-occlusive crisis. Although ambulatory pain accounts for most days in pain, pain is also the most common cause...
9.
Dampier C, Wager C, Harrison R, Hsu L, Minniti C, Smith W
Am J Hematol
. 2012 Aug;
87(10):E71-4.
PMID: 22886853
No abstract available.
10.
Miller S, Kim H, Weiner D, Wager C, Gallagher D, Styles L, et al.
Transfusion
. 2012 Jul;
53(4):704-9.
PMID: 22804353
Background: Transfusion of red blood cells (RBCs) is frequently required for care of individuals with sickle cell disease (SCD). Alloimmunization rates are high and may be reduced by matching for...